Pinterest • The world’s catalogue of ideas - IDWeek 2016: Electronic Health Records Can Help Select Candidates for HIV PrEP | Pre-exposure Prophylaxis (PrEP)

New Resource: “Is PrEP Right for Me?” - a simple web survey to see if pre-exposure prophylaxis could be perfect for protecting you against HIV.

pin 2
heart 1

Pre-exposure treatment to help prevent HIV: Wider use of Pre-Exposure Prophylaxis (PrEP), where people who don’t have HIV take a pill every day, could prevent around 7,400 new HIV infections in the UK by 2020. David Rowlands examines the evidence and calls for the NHS to follow France in offering the treatment for most-at-risk populations.

Better Life For Local HIV Patients and Other News - Read here: #News

High Court rules NHS England has the power to provide ‘game-changing’ HIV drug

NHS England has lost its appeal over a High Court ruling that it has the legal power to commission PrEP, a “game-changing” preventative HIV/Aids drug. PrEP, short for “pre-exposure prophylaxis”, is a prevention strategy which involves people who are HIV negative but at high risk of infection taking the anti-retroviral drug Truvada to reach optimal levels of protection.

Pre-exposure prophylaxis of HIV in adults at high risk: Truvada (emtricitabine/tenofovir disoproxil) | Key-points-from-the-evidence | Advice | NICE

The World Health Organization guidelines recommend HIV treatment for all: The guidelines are calling for universal antiretroviral therapy for everyone diagnosed with HIV, regardless of CD4 T-cell count, and pre-exposure prophylaxis (PrEP) for people at risk of infection. The organization estimates that the recommendations, if widely adopted, could avert 21 million deaths and prevent 28 million new infections worldwide by 2030

HIV drug 'PREVENTS the virus developing in 100% of healthy gay men'

Scientists at the Kaiser Permanente San Francisco Medical Center gave Truvada, a pre-exposure prophylaxis (PrEP) to hundreds of gay men, and found that none of developed HIV.

pin 1

Tracking autism: a social neuroscientist’s hunt for autism biomarkers